Literature DB >> 20382907

Trastuzamab (Herceptin)-related cardiotoxicity in pregnancy.

Nicole J Roberts1, Barry J Auld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20382907      PMCID： PMC2853413          DOI： 10.1258/jrsm.2009.090260

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  10 in total

1.  Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.

Authors:  Arnim A Bader; Dietmar Schlembach; Karl F Tamussino; Gunda Pristauz; Edgar Petru
Journal:  Lancet Oncol       Date:  2007-01       Impact factor: 41.316

2.  Effect of adjuvant trastuzumab on pregnancy.

Authors:  Ashita M Waterston; John Graham
Journal:  J Clin Oncol       Date:  2006-01-10       Impact factor: 44.544

3.  Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?

Authors:  Michael S Ewer; Elizabeth Tan-Chiu
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

Review 4.  Trastuzumab in pregnancy associated with poor fetal outcome.

Authors:  I D Witzel; V Müller; E Harps; F Janicke; M Dewit
Journal:  Ann Oncol       Date:  2007-12-15       Impact factor: 32.976

Review 5.  Trastuzumab--mechanism of action and use in clinical practice.

Authors:  Clifford A Hudis
Journal:  N Engl J Med       Date:  2007-07-05       Impact factor: 91.245

6.  Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.

Authors:  Michelle A Fanale; Anne R Uyei; Richard L Theriault; Karolina Adam; Rachel A Thompson
Journal:  Clin Breast Cancer       Date:  2005-10       Impact factor: 3.225

7.  Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.

Authors:  William J Watson
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

8.  Serial study of factors influencing changes in cardiac output during human pregnancy.

Authors:  S C Robson; S Hunter; R J Boys; W Dunlop
Journal:  Am J Physiol       Date:  1989-04

Review 9.  Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.

Authors:  Alon Shrim; Facundo Garcia-Bournissen; Cynthia Maxwell; Dan Farine; Gideon Koren
Journal:  Reprod Toxicol       Date:  2007-02-25       Impact factor: 3.143

10.  Trastuzumab use for metastatic breast cancer in pregnancy.

Authors:  Renuka Sekar; Peter R Stone
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661
  10 in total
  2 in total

1.  Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.

Authors:  Lin-Yu Xia; Qing-Lin Hu; Qing Zhou
Journal:  BMC Womens Health       Date:  2021-04-21       Impact factor: 2.809

2.  Trastuzumab administration during pregnancy: an update.

Authors:  Angeliki Andrikopoulou; Kleoniki Apostolidou; Spyridoula Chatzinikolaou; Garyfalia Bletsa; Eleni Zografos; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal:  BMC Cancer       Date:  2021-04-26       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.